UCLA opens first engineered blood stem cell clinical trial for cancers with the NY-ESO-1 tumor marker – Newswise (press release)
|
UCLA opens first engineered blood stem cell clinical trial for cancers with the NY-ESO-1 tumor marker
Newswise (press release) Newswise — Scientists at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have initiated a phase 1 clinical trial to test a novel cancer treatment for certain kinds of cancers that have a specific tumor marker … |
|
UCLA opens first engineered blood stem cell clinical trial for cancers with the NY-ESO-1 tumor marker
Newswise (press release) Newswise — Scientists at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have initiated a phase 1 clinical trial to test a novel cancer treatment for certain kinds of cancers that have a specific tumor marker … |
|
Modulating T-Cell Metabolism Uncovers New Technology for Enhancing Immunotherapy
Newswise (press release) Newswise — PHILADELPHIA — (Sept. 11, 2017) — T lymphocytes found in tumors and implicated in killing tumor cells cope with the shortage of oxygen and nutrients in the tumor microenvironment by using fat as the main source of energy. Promoting a … |
|
Modulating T-Cell Metabolism Uncovers New Technology for Enhancing Immunotherapy
Newswise (press release) Newswise — PHILADELPHIA — (Sept. 11, 2017) — T lymphocytes found in tumors and implicated in killing tumor cells cope with the shortage of oxygen and nutrients in the tumor microenvironment by using fat as the main source of energy. Promoting a … |
|
UCLA opens first engineered blood stem cell clinical trial for cancers with the NY-ESO-1 tumor marker
Newswise (press release) Newswise — Scientists at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have initiated a phase 1 clinical trial to test a novel cancer treatment for certain kinds of cancers that have a specific tumor marker … |
Daily Mail |
Scientists use controversial CRISPR gene-editing tool to change the color of flowers for the first time
Daily Mail Using the CRISPR technique, researchers altered the flowers on morning glory plants from purple to white. By targeting a single gene rsponsible for the color of the plants’ flowers, stems, and leaves, they were able to change the color without altering … Changing a flower’s color with the CRISPR gene-editing toolNew Atlas DNA Editor Improves on CRISPR, Harvard Team SaysLaboratory Equipment Why Sweden doesn’t regulate CRISPR gene-edited crops as GMOs …Genetic Literacy Project The Global Health News (press release) (blog) –International Business Times UK –agprofessional.com all 10 news articles » |
|
Arcadia Biosciences Licenses Broad Institute CRISPR IP
GenomeWeb NEW YORK (GenomeWeb) – Ag-bio firm Arcadia Biosciences announced today that has it acquired a worldwide, nonexclusive license to the Broad Institute’s intellectual property on CRISPR-Cas9 genome-editing technology. According to Arcadia, the … Arcadia Biosciences To Accelerate Agricultural Trait Development with CRISPR-Cas9Business Wire (press release) |